Literature DB >> 33394054

Blinding, pragmatism, and the PRECIS-2 tool for designing and assessing randomized trials.

Merrick Zwarenstein1, Alison Howie2.   

Abstract

Year:  2021        PMID： 33394054     DOI： 10.1007/s00228-020-03078-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  2 in total

1.  The PRECIS-2 tool: designing trials that are fit for purpose.

Authors:  Kirsty Loudon; Shaun Treweek; Frank Sullivan; Peter Donnan; Kevin E Thorpe; Merrick Zwarenstein
Journal:  BMJ       Date:  2015-05-08

2.  The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.

Authors:  Rafael Dal-Ré
Journal:  Eur J Clin Pharmacol       Date:  2020-10-26       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.